Sandur Manganese Enters Medical Devices Market with Royal Sandur MedTech Subsidiary
Royal Sandur MedTech has been established with a broad mandate covering medical devices, surgical products, diagnostic products and healthcare consumables.
Bengaluru-based Sandur Manganese & Iron Ores has incorporated Royal Sandur MedTech as a wholly owned subsidiary, marking its entry into medical devices and healthcare consumables manufacturing.
The new entity will undertake manufacturing, processing, assembly, marketing, and distribution of products across the healthcare segment.
The move follows Sandur Manganese's broader diversification plans announced earlier in 2026, indicating plans to expand beyond its traditional metals businesses into sectors including hospitality, education and medical devices.
Royal Sandur MedTech was incorporated on September 25, 2026, with Sandur Manganese holding the entire share capital.
The parent company has subscribed to 10 lakh equity shares with a face value of INR 10 each, representing an initial investment of INR 1 Cr.
Royal Sandur MedTech has been established with a broad mandate covering medical devices, surgical products, diagnostic products, and healthcare consumables.
Its activities will include manufacturing, processing, assembling, marketing, and distribution, allowing the subsidiary to participate across multiple stages of the Medical Devices value chain.
Sandur Manganese is the flagship company of the Karnataka-based Sandur Group and operates manganese and iron ore mining activities in the Hosapete-Ballari region.
India's Medical Devices sector has been receiving greater policy attention as the country seeks to strengthen domestic manufacturing and reduce dependence on imports.
For new entrants such as Royal Sandur MedTech, regulatory approvals, quality certifications, product development, and healthcare distribution will be important considerations as the business moves from incorporation towards commercial operations.
Stay tuned for more such updates on Digital Health News